Skip to main content
TipRanks
Go Ultimate75% OFF

Adaptimmune Therapeutics (473A) Q4 2024 Earnings Report

0 Followers

DE:473A Q4 2024 EPS Results

Actual EPS
-EUR 0.04
Consensus EPS
-EUR 0.03
Beat/Miss
Missed by -EUR 0.02
One Year Ago EPS
-EUR 0.04

DE:473A Q4 2024 Revenue Results

Actual Revenue
EUR 2.86M
Expected Revenue
EUR 7.02M
Beat/Miss
Missed by -EUR 4.16M
YoY Revenue Growth
+1269.61%

Earnings Announcement Details

Quarter
Q4 2024
Date
03/20/2025
Time
Before Open
Conference Call
Thursday, March 20, 2025

Q4 2024 Earnings Call Audio

DE:473A Q4 2024 Earnings Call
0:00 / 0:00

Q4 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:473A Earnings History

DE:473A earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Aug 12, 20262026 (Q2)―--0.1―
May 20, 20262026 (Q1)-0.03--0.03―
Mar 10, 20262025 (Q4)-0.05-0.03-0.0440.00% (+0.02)
Nov 05, 20252025 (Q3)-0.11--0.01―
Aug 13, 20252025 (Q2)-0.04-0.020.04-150.00% (-0.05)
May 13, 20252025 (Q1)-0.08-0.03-0.030.00% (+0.00)
Mar 20, 20252024 (Q4)-0.03-0.04-0.04-25.00% (-0.01)
Nov 13, 20242024 (Q3)-0.01-0.01-0.0366.67% (+0.02)
Aug 12, 20242024 (Q2)-0.040.04-0.02300.00% (+0.05)
May 15, 20242024 (Q1)-0.14-0.030―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed